Jorge Conde

Jorge Conde is a General Partner at Andreessen Horowitz (a16z), where he leads investments at the intersection of biology, computer science, and engineering.12 His career spans over 20 years in the life sciences and healthcare sectors, with extensive experience in leadership, operations, and investing.4

Career Highlights

• Current Role: General Partner at Andreessen Horowitz (since 2017)3
• Previous Positions:
  • Chief Strategy Officer, Chief Financial Officer, and Chief Product Officer at Syros Pharmaceuticals13
  • Co-founder and CEO of Knome, a human genome interpretation company (acquired by Tute Genomics in 2015)13
  • Marketing and Operations Manager at MedImmune3
  • Biotechnology Investment Banker at Morgan Stanley13

Education

• MBA from Harvard Business School1
• MS from the Harvard-MIT Division of Health Sciences and Technology1
• BA in Biology from Johns Hopkins University1

Board Memberships

Jorge serves on the boards of several Andreessen Horowitz portfolio companies, including:

• Asimov
• CAMP4 Therapeutics
• Cartography Biosciences
• Dyno Therapeutics
• EQRx
• Komodo Health
• Octant Bio
• Earli Inc.3

Achievements and Recognition

• Named one of the top 35 young innovators in the world by MIT Technology Review1
• Henry Crown Fellow of the Aspen Institute1
• Member of the Aspen Global Leadership Network1

Personal

Born and raised in Miami by Cuban and Peruvian parents, Jorge is married to a Madrileña and lives in California with his family of six.4 He is fluent in both English and Spanish.3